£18.70
Instantly refresh and hydrate your skin with The INKEY List Hydro-Surge Dewy Face Mist, designed for immediate moisture delivery wherever you are. This mist provides clinically proven hydration that lasts for up to 12 hours, combating tightness and dullness caused by environmental factors. Experience an instant glow that sets beautifully, even over applied makeup.
- Clinically proven to deliver 12-hour continuous hydration for lasting comfort.
- Promotes an immediate dewy glow, enhancing the skin’s natural radiance.
- Suitable for sensitive skin types, offering a gentle soothing effect.
- Perfect for use on long journeys, in air-conditioned environments, or post-exercise.
- Replaces lost skin water content to relieve tightness and dullness.
Keep this essential 75ml facial spray handy for skin that requires frequent replenishment.
Read MoreDescription
xThe INKEY List Hydro-Surge Dewy Face Mist 75ml
Introducing Hydro-Surge Dewy Face Mist, for instant, on-the-go hydration.
Whether you’re on a long-haul flight, in an overly air-conditioned office or just finished a workout - INKEY says ‘spritz.’
Clinically proven to deliver 12-hour hydration. Promoting an instant glow - even over makeup proven to sooth even the most sensitive skin*
Your skin’s thirsty. You lose up to 2L of water every day and with skin made up of 64% water, it’s no surprise it can start feeling tight, dull or dehydrated. Just like your body needs water on the go, your skin does too.
This ultra-fine, cloud-like mist is clinically proven to instantly hydrate and lock it in for 12 hours. No messing with your makeup or SPF.
Powered by 3 active ingredients and backed by science.
3% Hydroviton® Insta – Delivers instant and long-lasting 12-hour hydration.
3% Aquaxyl™ – Strengthens your skin barrier to hold onto moisture and reduce water loss.
2% Earth Marine Water - Adds a natural glow, whether it’s bare skin or over makeup.
Spritz when your skin needs it most. Mist. Glow. Go!
Fragrance-free. Alcohol-free. Suitable for sensitive skin.
*96-hr clinical patch-test on 31 people & 2-week consumer trial of 103 people
